Navigation Links
Leading Ag Biotechnology Companies in Europe and America Save 50-80% of Field Study Management Time with eStudy
Date:5/19/2011

CARY, N.C., May 19, 2011 /PRNewswire/ -- iAdvantage Software, Inc. (iAdvantage), known for its flexible 100% web-based Life Science Study Management Platform, eStudy™, today announced that eStudy is being successfully used globally by Leading European and USA Ag Biotechnology Companies.  These companies reduce time-to-results with eStudy's on-line study design, management, communication, data collection and reporting of Biotechnology Field Studies, including gene expression, protein analysis, protein expression, nutrient composition, agronomics, etc.  Clients report 50-80% savings of field study management time by eliminating paper shuffling, transcription errors and generating reports in real-time.

(Logo: http://photos.prnewswire.com/prnh/20110309/CL62195LOGO)

"Utilizing eStudy to manage Projects/Studies electronically across the globe IMPROVES PRODUCTIVITY and provides IMMEDIATE ACCESS TO RESULTS," stated Fate Thompson, CEO/President of iAdvantage Software.  "Project Managers and Study Directors make decisions to restart or redirect trials and studies, SAVING TIME and MONEY and ENSURING THAT NO TRIAL IS LOST.  This is critical," Thompson continued. "A lost trial could potentially cost a full development year for an Agricultural, Chemical or Biotechnology product."

"eStudy creates even more value when eStudy APHIS and eQA are included to manage the field trial compliance data management requirement of USDA/APHIS/BRS, EPA and other regulatory authorities," Thompson emphasized. eStudy REDUCES QA and DATA MANAGEMENT COSTS and ENSURES DATA INTEGRITY AND COMPLIANCE.

The eStudy Platform is comprised of two unique environments, the eStudy Manager and the eNotebook.  In eStudy Manager, Study Directors, Project Managers, and QA perform multiple tasks.  They design and Track Studies/Trials in Real-Time; Track Sample Movement; Communicate Results by generating Status, Interim, Draft and/or Final Reports instantaneously in Word, pdf or Excel with ePublisher; Query the data with DataCipher for review or statistical analysis; Assure and Report Compliance Status; Process and Report QA Audits and APHIS Compliance (in USA).

In eNotebook Field Trial Investigators collect data in secure, user-friendly, intuitive electronic notebooks designed specifically for biotechnology studies.  Data is entered on-line or off-line via a laptop, tablet PC or iPad. eNotebook supports EPA/PMRA/OECD/GLP and 21 CFR Part 11 compliance requirements for data integrity and data capture and comes complete with Audit Trail reports tracking all data entered and/or changed.

"eStudy's Platform flexibility will meet your needs today, and grow with your company tomorrow," concluded Thompson.

About iAdvantage Software

iAdvantage empowers scientists and management in the pharmaceutical and biotechnology arenas with efficient, web-based electronic study management and reporting tools, while supporting GLP and 21 CFR Part 11 compliance.  iAdvantage is headquartered in Cary, North Carolina, near the life science and biotech hub of Research Triangle Park.  More than 140 life science companies in North America and Europe use iAdvantage products.  For more information, contact Diana Michelotti, Director of Marketing and Sales - 919 469-3888 x121, email dmichelotti@iadvantagesoftware.com or visit our website at www.iadvantagesoftware.com.


'/>"/>
SOURCE iAdvantage Software, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. At This Years American Academy of AntiAging (A4M) Conference, Glycation and AGEs (Advanced Glycation End Products) Were Named the Leading Factors in Premature Aging and Disease
2. Dune Medicals MarginProbe™ Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re-excision in Landmark Lumpectomy Surgery Trial
3. Brain regions can take short naps during wakefulness, leading to errors
4. ERT Awarded over $10 Million of ePRO Business from Major Pharma - Increasing its Position as a Leading ePRO Provider
5. Reportlinker Adds The 2011 Top Ten Worlds Leading Life Science Intermediates Companies
6. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
7. RadQual, LLC Announces a New Industry Leading Dose Calibrator Reference Standard
8. Leading Animal Stem Cell Developer MediVet-America Achieves Significant Business Growth Milestones in First Year
9. MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services
10. Leading Scientific Laboratory Offers New Methods for Metals Testing
11. Leading Dental Stem Cell and Regenerative Medicine Researcher Dr. George Huang Joins StemSaves Science Advisory Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):